Assura PLC Scrip Dividend Calculation (8610B)

TIDMAGR

RNS Number : 8610B

Assura PLC

15 January 2018

15 January 2018

Assura plc

Scrip Dividend Declaration

Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, today announces that, pursuant to its Scrip Dividend Scheme and in response to the scrip dividend alternative for the quarterly interim dividend payable on 17 January 2018 (the "Scrip Dividend Alternative"), elections were received in respect of 28 per cent. of the Company's ordinary shares in issue as at the record date of 15 December 2017.

Electing shareholders will receive ordinary shares in the Company ("Shares") in lieu of cash in respect of this dividend and, accordingly 7,293,146 Shares (the "New Shares") will be issued by the Company to such shareholders.

Application has therefore been made for the admission of the New Shares to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's market for listed securities ("Admission"). The New Shares will rank pari passu with the Company's existing ordinary shares and Admission is expected to occur at 8.00am on 17 January 2018.

Following the allotment of the New Shares, it is expected that the total number of shares in issue will be 2,383,122,112 (none of which will be held in treasury) and that, accordingly, the total number of voting rights of the Company will be 2,383,122,112.

Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism (http://www.morningstar.co.uk/uk/NSM).

This interim dividend is 100% ordinary dividend (non-PID).

Forms to register for gross PIDs (on future interim dividends) are available on the Company's website. Please click here for PID Forms.

-ENDS-

For more information, please contact:

 
 
    Assura plc    Tel: [phone] 
  Orla Ball 
 
 
  Edelman 
  John Kiely      Tel: [phone] 
Mav Wynn 
Rob Yates 
 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 30 September 2017, Assura's property portfolio was valued at GBP1.56 billion.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association

This information is provided by RNS

The company news service from the London Stock Exchange

END

DIVGCGDBUSBBGIU

(END) Dow Jones Newswires

January 15, 2018 04:46 ET (09:46 GMT)